Macquarie Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-6,978
Closed -$144K – 2205
2022
Q3
$144K Sell
6,978
-1,027
-13% -$13.5K ﹤0.01% 1677
2022
Q2
$77K Buy
8,005
+6,978
+679% +$87.6K ﹤0.01% 1941
2022
Q1
$17K Hold
1,027
– – ﹤0.01% 2428
2021
Q4
$17K Sell
1,027
-1,346
-57% -$22.1K ﹤0.01% 2437
2021
Q3
$39K Sell
2,373
-2,472
-51% -$26.9K ﹤0.01% 2304
2021
Q2
$31K Buy
+4,845
New +$31.3K ﹤0.01% 2263
2020
Q2
– Sell
-11,225
Closed -$39K – 2415
2020
Q1
$39K Buy
+11,225
New +$65.6K ﹤0.01% 1842
2019
Q1
– Sell
-1,147
Closed -$1K – 2136
2018
Q4
$1K Sell
1,147
-31,954
-97% -$61.9K ﹤0.01% 2230
2018
Q3
$78K Sell
33,101
-159,499
-83% -$398K ﹤0.01% 1643
2018
Q2
$526K Sell
192,600
-13,900
-7% -$38.3K ﹤0.01% 1348
2018
Q1
$566K Buy
206,500
+167,600
+431% +$486K ﹤0.01% 1348
2017
Q4
$121K Buy
38,900
+23,900
+159% +$67.2K ﹤0.01% 1867
2017
Q3
$42K Buy
+15,000
New +$40.5K ﹤0.01% 2021

Other funds holding ISEE

Macquarie Group's ISEE Position: Q4 2022 in Review

Macquarie Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 6,978 shares — an estimated $144K sold.

Macquarie Group first reported a position in ISEE in Q3 2017 and held it in 13 quarters. The position peaked at $566K in Q1 2018. 223 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Macquarie Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 6,978 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $144K.
  • Macquarie Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
  • Macquarie Group's IVERIC bio, Inc. Common Stock position peaked at $566K in Q1 2018.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.